What is TTRX's debt-to-equity?

TTRX (TTRX) reported debt-to-equity of 1× in Q1 2026.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

TTRX TTRX Debt-to-equity

Debt-to-equity at other companies

Regeneron PharmaceuticalsREGN

0.1×0.0×

Journey Medical CorporationDERM

0.8×-0.3×

PTH

Pelthos Therapeutics Inc.PTHS

0.8×—

Celldex TherapeuticsCLDX

0×0.0×

Arcutis Biotherapeutics, Inc.ARQT

0.6×-0.2×

Kymera TherapeuticsKYMR

0.1×-0.1×

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

total debt/total stockholders equity=1×

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's debt-to-equity?: TTRX (TTRX) reported debt-to-equity of 1× in Q1 2026.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.